We also found that the application of H4R antagonists reverses the inflammatory effect associated with the Th2/Tc2 profile, a mechanism that involves an immunosuppressive response, dependent, in part, on IL-10 production, leading to an improvement in the symptoms associated with dermatitis. The gene discussed is HRH4; the disease is dermatitis.